(Total Views: 316)
Posted On: 04/18/2019 11:47:02 AM
Post# of 145915
I don'now , but I will think pivotal mono should be 24 weeks since we are going threw Investigative phase 3 now , many patients and 48 weeks ..
But FDA will do what they want to do of course ,
I feel that even if it will take all new patients , but efficacy was significantly better with longer overlap of 3 weeks instead 1 week with investigative phase 3, we should do longer overlap.
We should not need more than 150 patients...
This is mine wish list !!!!
But FDA will do what they want to do of course ,
I feel that even if it will take all new patients , but efficacy was significantly better with longer overlap of 3 weeks instead 1 week with investigative phase 3, we should do longer overlap.
We should not need more than 150 patients...
This is mine wish list !!!!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)